This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance through March 6, 2026.
Novocure holds a 5-year Federal Supply Schedule (FSS) contract with the VA VHA, worth up to $28.85 million, that provides a streamlined procurement vehicle for the VA to obtain Novocure's Optune TTFields therapy products and services. This specific award is likely a delivery order issued under the FSS contract, enabling VA medical centers nationwide to offer Novocure's non-invasive cancer treatment option to veteran patients. The contract does not utilize any set-aside designations, as Novocure's specialized medical device offerings make it the sole source provider.
Generated 3/11/25, 9:46 AM